Company / Operating Cash Flow
Penumbra, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$238.7M
FY2025
5-year range
-$33.2M / $238.7M
FY2021-FY2025
Trend
+41.7%
vs FY2024
Sector context
#79 of 164
Health Care
What the data says
At $239M, Penumbra, Inc.'s operating cash flow ranks #79 of 164 in the Health Care sector. Operating Cash Flow has increased for 3 consecutive years, from -$33M in FY2022 to $239M in FY2025.
Based on SEC 10-K filings.
$239M in FY2025.
Improved from $97M to $239M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#79 of 164 in Health CareTop 48% of 164This company $238.7M Sector average $1.0B
▼
-77.1% below sector average
Key checks
Key Insights
- Penumbra, Inc.'s operating cash flow has grown for 3 consecutive years.
- In FY2025, operating cash flow increased 41.7% year-over-year.
- Ranks #79 out of 164 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.11 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $238.7M | +41.7% |
| FY2024 | $168.5M | +73.1% |
| FY2023 | $97.3M | +392.8% |
| FY2022 | -$33.2M | -224.7% |
| FY2021 | $26.7M | +180.2% |
| FY2020 | -$33.2M | -361.9% |
| FY2019 | $12.7M | +199.1% |
| FY2018 | -$12.8M | +38.1% |
| FY2017 | -$20.7M | -61.5% |
| FY2016 | -$12.8M | +38.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026